help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dvorak, H. F.
Right arrow Articles by Dvorak, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dvorak, H. F.
Right arrow Articles by Dvorak, A. M.

American Journal of Pathology, Vol 133, 95-109, Copyright © 1988 by American Society for Investigative Pathology

REGULAR ARTICLES

Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules

HF Dvorak, JA Nagy, JT Dvorak and AM Dvorak
Department of Pathology, Beth Israel Hospital, Boston, MA 02215.

The tumor microvasculature is hyperpermeable to plasma proteins, but the specific vessels that leak have not been identified. To investigate this question, the extravasation of circulating tracers of varying size was studied by fluorescence, light, and electron microscopy in animals bearing solid transplantable carcinomas. In all five tumors studied, 70 and 150 kD fluoresceinated (FITC)-dextrans and colloidal carbon leaked extensively from the prominent vascular plexus that was induced around individual tumor nodules and at the tumor-host interface. Leaky vessels were mature veins or venules, lined by a continuous endothelium; most had closed interendothelial cell junctions. Immature interface vessels and tumor-penetrating vessels did not leak these macromolecular tracers significantly. Three kD of FITC-dextran leaked from peripherally situated tumor veins or venules but also extravasated from tumor- penetrating vessels and capillaries supplying normal tissues. These data correlate the functional and anatomic heterogeneity of tumor vessels and provide a rationale for the distribution of circulating molecules such as monoclonal antibodies and tumoricidal drugs in solid tumors.


This article has been cited by other articles:


Home page
 RadiologyHome page
H.-J. Raatschen, G. H. Simon, Y. Fu, B. Sennino, D. M. Shames, M. F. Wendland, D. M. McDonald, and R. C. Brasch
Vascular Permeability during Antiangiogenesis Treatment: MR Imaging Assay Results as Biomarker for Subsequent Tumor Growth in Rats
Radiology, May 1, 2008; 247(2): 391 - 399.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. R. Dreher and A. Chilkoti
Toward a Systems Engineering Approach to Cancer Drug Delivery
J Natl Cancer Inst, July 4, 2007; 99(13): 983 - 985.
[Full Text] [PDF]

Home page
 RadiologyHome page
L. S. Fournier, V. Novikov, V. Lucidi, Y. Fu, T. Miller, E. Floyd, D. M. Shames, and R. C. Brasch
MR Monitoring of Cyclooxygenase-2 Inhibition of Angiogenesis in a Human Breast Cancer Model in Rats
Radiology, April 1, 2007; 243(1): 105 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. I. Lin, J. Yu, T. Murata, and W. C. Sessa
Caveolin-1-Deficient Mice Have Increased Tumor Microvascular Permeability, Angiogenesis, and Growth
Cancer Res., March 15, 2007; 67(6): 2849 - 2856.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Koizumi, M. Kitagawa, T. Negishi, T. Onda, S.-i. Matsumoto, T. Hamaguchi, and Y. Matsumura
Novel SN-38-Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor-Secreting Bulky Tumors.
Cancer Res., October 15, 2006; 66(20): 10048 - 10056.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. R. Dreher, W. Liu, C. R. Michelich, M. W. Dewhirst, F. Yuan, and A. Chilkoti
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.
J Natl Cancer Inst, March 1, 2006; 98(5): 335 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Nakahara, S. M. Norberg, D. R. Shalinsky, D. D. Hu-Lowe, and D. M. McDonald
Effect of Inhibition of Vascular Endothelial Growth Factor Signaling on Distribution of Extravasated Antibodies in Tumors
Cancer Res., February 1, 2006; 66(3): 1434 - 1445.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
L. A. Diaz Jr., I. Cheong, C. A. Foss, X. Zhang, B. A. Peters, N. Agrawal, C. Bettegowda, B. Karim, G. Liu, K. Khan, et al.
Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores
Toxicol. Sci., December 1, 2005; 88(2): 562 - 575.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
M. van Vliet, C. F. van Dijke, P. A. Wielopolski, T. L. M. ten Hagen, J. F. Veenland, A. Preda, A. J. Loeve, A. M. M. Eggermont, and G. P. Krestin
MR Angiography of Tumor-related Vasculature: From the Clinic to the Micro-environment
RadioGraphics, October 1, 2005; 25(suppl_1): S85 - S97.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. E. McNeil
Nanotechnology for the biologist
J. Leukoc. Biol., September 1, 2005; 78(3): 585 - 594.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
W.-Y. Yue and Z.-P. Chen
Does Vasculogenic Mimicry Exist in Astrocytoma?
J. Histochem. Cytochem., August 1, 2005; 53(8): 997 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Parsons-Wingerter, I. M. Kasman, S. Norberg, A. Magnussen, S. Zanivan, A. Rissone, P. Baluk, C. J. Favre, U. Jeffry, R. Murray, et al.
Uniform Overexpression and Rapid Accessibility of {alpha}5{beta}1 Integrin on Blood Vessels in Tumors
Am. J. Pathol., July 1, 2005; 167(1): 193 - 211.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Seshadri, J. A. Spernyak, R. Mazurchuk, S. H. Camacho, A. R. Oseroff, R. T. Cheney, and D. A. Bellnier
Tumor Vascular Response to Photodynamic Therapy and the Antivascular Agent 5,6-Dimethylxanthenone-4-Acetic Acid: Implications for Combination Therapy
Clin. Cancer Res., June 1, 2005; 11(11): 4241 - 4250.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Magnussen, I. M. Kasman, S. Norberg, P. Baluk, R. Murray, and D. M. McDonald
Rapid Access of Antibodies to {alpha}5{beta}1 Integrin Overexpressed on the Luminal Surface of Tumor Blood Vessels
Cancer Res., April 1, 2005; 65(7): 2712 - 2721.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Podar and K. C. Anderson
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
Blood, February 15, 2005; 105(4): 1383 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. R. Enis, B. R. Shepherd, Y. Wang, A. Qasim, C. M. Shanahan, P. L. Weissberg, M. Kashgarian, J. S. Pober, and J. S. Schechner
Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells
PNAS, January 11, 2005; 102(2): 425 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Kobayashi, K. Reijnders, S. English, A. T. Yordanov, D. E. Milenic, A. L. Sowers, D. Citrin, M. C. Krishna, T. A. Waldmann, J. B. Mitchell, et al.
Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation
Clin. Cancer Res., November 15, 2004; 10(22): 7712 - 7720.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Swenson, F. Costa, R. Minea, R. P. Sherwin, W. Ernst, G. Fujii, D. Yang, and F. S. Markland Jr.
Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression
Mol. Cancer Ther., April 1, 2004; 3(4): 499 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
M. L. Wahl, T. L. Moser, and S. V. Pizzo
Angiostatin and Anti-angiogenic Therapy in Human Disease
Recent Prog. Horm. Res., January 1, 2004; 59(1): 73 - 104.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. W. Snowden, L. Zhang, F. Urnov, C. Dent, Y. Jouvenot, X. Zhong, E. J. Rebar, A. C. Jamieson, H. S. Zhang, S. Tan, et al.
Repression of Vascular Endothelial Growth Factor A in Glioblastoma Cells Using Engineered Zinc Finger Transcription Factors
Cancer Res., December 15, 2003; 63(24): 8968 - 8976.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
G M Tozer
Measuring tumour vascular response to antivascular and antiangiogenic drugs
Br. J. Radiol., December 1, 2003; 76(suppl_1): S23 - S35.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H. E. Daldrup-Link, J. Rydland, T. H. Helbich, A. Bjornerud, K. Turetschek, K. A. Kvistad, E. Kaindl, T. M. Link, K. Staudacher, D. Shames, et al.
Quantification of Breast Tumor Microvascular Permeability with Feruglose-enhanced MR Imaging: Initial Phase II Multicenter Trial
Radiology, December 1, 2003; 229(3): 885 - 892.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Chen, Z. Ai, M. Rasmussen, P. Bajcsy, L. Auvil, M. Welge, L. Leach, S. Vangveeravong, A. J. Maniotis, and R. Folberg
Three-Dimensional Reconstruction of Extravascular Matrix Patterns and Blood Vessels in Human Uveal Melanoma Tissue: Techniques and Preliminary Findings
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2834 - 2840.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Easwaran, S. H. Lee, L. Inge, L. Guo, C. Goldbeck, E. Garrett, M. Wiesmann, P. D. Garcia, J. H. Fuller, V. Chan, et al.
{beta}-Catenin Regulates Vascular Endothelial Growth Factor Expression in Colon Cancer
Cancer Res., June 15, 2003; 63(12): 3145 - 3153.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Rybak, E. Sanovich, M. G. Hollingshead, S. D. Borgel, D. L. Newton, G. Melillo, D. Kong, G. Kaur, and E. A. Sausville
"Vasocrine" Formation of Tumor Cell-lined Vascular Spaces: Implications for Rational Design of Antiangiogenic Therapies
Cancer Res., June 1, 2003; 63(11): 2812 - 2819.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
S. M. Jilani, T. J. Murphy, S. N.M. Thai, A. Eichmann, J. A. Alva, and M. L. Iruela-Arispe
Selective Binding of Lectins to Embryonic Chicken Vasculature
J. Histochem. Cytochem., May 1, 2003; 51(5): 597 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S. SINHA and U. SINHA
Functional Magnetic Resonance of Human Breast Tumors: Diffusion and Perfusion Imaging
Ann. N.Y. Acad. Sci., December 1, 2002; 980(1): 95 - 115.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Koolpe, M. Dail, and E. B. Pasquale
An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor
J. Biol. Chem., November 27, 2002; 277(49): 46974 - 46979.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
Y.-J. Lee, N. Nagai, C.-H. Siar, K. Nakano, H. Nagatsuka, H. Tsujigiwa, C.-H. Roan, and M. Gunduz
Angioarchitecture of Primary Oral Malignant Melanomas
J. Histochem. Cytochem., November 1, 2002; 50(11): 1555 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J.-P. Delille, P. J. Slanetz, E. D. Yeh, D. B. Kopans, and L. Garrido
Breast Cancer: Regional Blood Flow and Blood Volume Measured with Magnetic Susceptibility-based MR Imaging—Initial Results
Radiology, March 21, 2002; (2002) 2232010428.
[Abstract] [Full Text]

Home page
 JCOHome page
A. J. Guidi, D. A. Berry, G. Broadwater, B. Helmchen, I. J. Bleiweiss, D. R. Budman, I. C. Henderson, L. Norton, and D. F. Hayes
Association of Angiogenesis and Disease Outcome in Node-Positive Breast Cancer Patients Treated With Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil: A Cancer and Leukemia Group B Correlative Science Study From Protocols 8541/8869
J. Clin. Oncol., February 1, 2002; 20(3): 732 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
B. S. Kuszyk, F. M. Corl, F. N. Franano, D. A. Bluemke, L. V. Hofmann, B. J. Fortman, and E. K. Fishman
Tumor Transport Physiology: Implications for Imaging and Imaging-Guided Therapy
Am. J. Roentgenol., October 1, 2001; 177(4): 747 - 753.
[Full Text] [PDF]

Home page
 JCOHome page
A. N. Gordon, J. T. Fleagle, D. Guthrie, D. E. Parkin, M. E. Gore, and A. J. Lacave
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
J. Clin. Oncol., July 15, 2001; 19(14): 3312 - 3322.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. S. Soukos, M. R. Hamblin, S. Keel, R. L. Fabian, T. F. Deutsch, and T. Hasan
Epidermal Growth Factor Receptor-targeted Immunophotodiagnosis and Photoimmunotherapy of Oral Precancer in Vivo
Cancer Res., June 1, 2001; 61(11): 4490 - 4496.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Ezaki, P. Baluk, G. Thurston, A. La Barbara, C. Woo, and D. M. McDonald
Time Course of Endothelial Cell Proliferation and Microvascular Remodeling in Chronic Inflammation
Am. J. Pathol., June 1, 2001; 158(6): 2043 - 2055.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. M. Ballangrud, W.-H. Yang, D. E. Charlton, M. R. McDevitt, K. A. Hamacher, K. S. Panageas, D. Ma, N. H. Bander, D. A. Scheinberg, and G. Sgouros
Response of LNCaP Spheroids after Treatment with an {{alpha}}-Particle Emitter (213Bi)-labeled Anti-Prostate-specific Membrane Antigen Antibody (J591)
Cancer Res., March 1, 2001; 61(5): 2008 - 2014.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
N. Liu, R. K. Lapcevich, C. B. Underhill, Z. Han, F. Gao, G. Swartz, S. M. Plum, L. Zhang, and S. J. Green
Metastatin: A Hyaluronan-binding Complex from Cartilage That Inhibits Tumor Growth
Cancer Res., February 1, 2001; 61(3): 1022 - 1028.
[Abstract] [Full Text]

Home page
 RadiologyHome page
K. Turetschek, S. Huber, E. Floyd, T. Helbich, T. P. L. Roberts, D. M. Shames, K. S. Tarlo, M. F. Wendland, and R. C. Brasch
MR Imaging Characterization of Microvessels in Experimental Breast Tumors by Using a Particulate Contrast Agent with Histopathologic Correlation
Radiology, February 1, 2001; 218(2): 562 - 569.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
D. L. Emerson, R. Bendele, E. Brown, S. Chiang, J. P. Desjardins, L. C. Dihel, S. C. Gill, M. Hamilton, J. D. LeRay, L. Moon-McDermott, et al.
Antitumor Efficacy, Pharmacokinetics, and Biodistribution of NX 211: A Low-Clearance Liposomal Formulation of Lurtotecan
Clin. Cancer Res., July 1, 2000; 6(7): 2903 - 2912.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
K. J. Bayless, R. Salazar, and G. E. Davis
RGD-Dependent Vacuolation and Lumen Formation Observed during Endothelial Cell Morphogenesis in Three-Dimensional Fibrin Matrices Involves the {alpha}v{beta}3 and {alpha}5{beta}1 Integrins
Am. J. Pathol., May 1, 2000; 156(5): 1673 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Hashizume, P. Baluk, S. Morikawa, J. W. McLean, G. Thurston, S. Roberge, R. K. Jain, and D. M. McDonald
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Am. J. Pathol., April 1, 2000; 156(4): 1363 - 1380.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Ganly, D. Kirn, S. G. Eckhardt, G. I. Rodriguez, D. S. Soutar, R. Otto, A. G. Robertson, O. Park, M. L. Gulley, C. Heise, et al.
A Phase I Study of Onyx-015, an E1B Attenuated Adenovirus, Administered Intratumorally to Patients with Recurrent Head and Neck Cancer
Clin. Cancer Res., March 1, 2000; 6(3): 798 - 806.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. J. Lim, D. Masin, N. L. McIntosh, T. D. Madden, and M. B. Bally
Role of Drug Release and Liposome-Mediated Drug Delivery in Governing the Therapeutic Activity of Liposomal Mitoxantrone Used to Treat Human A431 and LS180 Solid Tumors
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 337 - 345.
[Abstract] [Full Text]

Home page
 JCOHome page
M. I. Koukourakis, S. Koukouraki, A. Giatromanolaki, S. C. Archimandritis, J. Skarlatos, K. Beroukas, J. G. Bizakis, G. Retalis, N. Karkavitsas, and E. S. Helidonis
Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non-Small-Cell Lung Cancer and Head and Neck Cancer
J. Clin. Oncol., November 1, 1999; 17(11): 3512 - 3521.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R.-L. Hong, C.-J. Huang, Y.-L. Tseng, V. F. Pang, S.-T. Chen, J.-J. Liu, and F.-H. Chang
Direct Comparison of Liposomal Doxorubicin with or without Polyethylene Glycol Coating in C-26 Tumor-bearing Mice: Is Surface Coating with Polyethylene Glycol Beneficial?
Clin. Cancer Res., November 1, 1999; 5(11): 3645 - 3652.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Gossmann, Y. Okuhata, D. M. Shames, T. H. Helbich, T. P. L. Roberts, M. F. Wendland, S. Huber, and R. C. Brasch
Prostate Cancer Tumor Grade Differentiation with Dynamic Contrast-enhanced MR Imaging in the Rat: Comparison of Macromolecular and Small-Molecular Contrast Media-Preliminary Experience
Radiology, October 1, 1999; 213(1): 265 - 272.
[Abstract] [Full Text]

Home page
 ScienceHome page
M. S. O'Reilly, S. Pirie-Shepherd, W. S. Lane, and J. Folkman
Antiangiogenic Activity of the Cleaved Conformation of the Serpin Antithrombin
Science, September 17, 1999; 285(5435): 1926 - 1928.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
W. L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H. A. Weich, V. P. Torchilin, F. Yuan, and R. K. Jain
Augmentation of Transvascular Transport of Macromolecules and Nanoparticles in Tumors Using Vascular Endothelial Growth Factor
Cancer Res., August 1, 1999; 59(16): 4129 - 4135.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Krol, J. Maresca, M. W. Dewhirst, and F. Yuan
Available Volume Fraction of Macromolecules in the Extravascular Space of a Fibrosarcoma: Implications for Drug Delivery
Cancer Res., August 1, 1999; 59(16): 4136 - 4141.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
C. C. Michel and F. E. Curry
Microvascular Permeability
Physiol Rev, July 1, 1999; 79(3): 703 - 761.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Burg, R. Pasqualini, W. Arap, E. Ruoslahti, and W. B. Stallcup
NG2 Proteoglycan-binding Peptides Target Tumor Neovasculature
Cancer Res., June 1, 1999; 59(12): 2869 - 2874.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Tozer, V. E. Prise, J. Wilson, R. J. Locke, B. Vojnovic, M. R. L. Stratford, M. F. Dennis, and D. J. Chaplin
Combretastatin A-4 Phosphate as a Tumor Vascular-Targeting Agent: Early Effects in Tumors and Normal Tissues
Cancer Res., April 1, 1999; 59(7): 1626 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. A. Gelmon, A. Tolcher, A. R. Diab, M. B. Bally, L. Embree, N. Hudon, C. Dedhar, D. Ayers, A. Eisen, B. Melosky, et al.
Phase I Study of Liposomal Vincristine
J. Clin. Oncol., February 1, 1999; 17(2): 697 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
PNAS, April 14, 1998; 95(8): 4607 - 4612.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Pal, K. Datta, R. Khosravi-Far, and D. Mukhopadhyay
Role of Protein Kinase Czeta in Ras-mediated Transcriptional Activation of Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression
J. Biol. Chem., January 19, 2001; 276(4): 2395 - 2403.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J.-P. Delille, P. J. Slanetz, E. D. Yeh, D. B. Kopans, and L. Garrido
Breast Cancer: Regional Blood Flow and Blood Volume Measured with Magnetic Susceptibility-based MR Imaging—Initial Results
Radiology, May 1, 2002; 223(2): 558 - 565.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society for Investigative Pathology.